Acusphere, Inc. is a pharmaceutical company, which engages in the development of drugs and formulations of existing drugs using proprietary micro particle technology. The company is headquartered in Lexington, Massachusetts. The company went IPO on 2003-10-08. The firm is focused on the development of Imagify, which contains Perflubutane Polymer Microspheres for injectable suspension. The firm's product Imagify is a cardiovascular drug for the detection of coronary artery disease (CAD). Imagify injectable suspension consists of porous, synthetic polymer microspheres containing gas that are administered intravenously and act as tracers of blood flow or perfusion. The firm has submitted the Marketing Authorization Application (MAA) for its lead product candidate, Imagify lyophilisate for dispersion for injection with the European Medicines Agency (EMA) to support the regulatory review of Imagify in the European Union (EU).
Follow-Up Questions
Acusphere Inc (ACUS)'in P/E oranı nedir?
Acusphere Inc 'in P/E oranı 0 'dir
Acusphere Inc 'in CEO'su kimdir?
Mr. Mark Leuchtenberger 2013 'den beri şirketle birlikte olan Acusphere Inc 'in President 'ıdır.
ACUS hissesinin fiyat performansı nasıl?
ACUS 'in mevcut fiyatı $0 'dir, son işlem günde 0% decreased etti.
Acusphere Inc için ana iş temaları veya sektörler nelerdir?
Acusphere Inc Pharmaceuticals endüstrisine ait ve sektör Health Care 'dir
Acusphere Inc 'in piyasa değerlemesi nedir?
Acusphere Inc 'in mevcut piyasa değerlemesi $0 'dir
